Thomas Stephan
Stock Analyst at Stifel
(1.44)
# 3,534
Out of 5,182 analysts
60
Total ratings
35.14%
Success rate
-7.31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Thomas Stephan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group | Maintains: Hold | $115 → $130 | $113.21 | +14.83% | 2 | Mar 9, 2026 | |
| OFIX Orthofix Medical | Maintains: Buy | $22 → $18 | $12.15 | +48.15% | 2 | Mar 9, 2026 | |
| ATEC Alphatec Holdings | Maintains: Buy | $24 → $20 | $10.21 | +95.89% | 3 | Mar 9, 2026 | |
| ALC Alcon | Maintains: Hold | $80 → $82 | $75.86 | +8.09% | 7 | Mar 9, 2026 | |
| STAA STAAR Surgical Company | Maintains: Hold | $19 → $18 | $24.84 | -27.54% | 12 | Mar 4, 2026 | |
| SGHT Sight Sciences | Maintains: Buy | $6 → $8 | $4.32 | +85.19% | 8 | Mar 2, 2026 | |
| GKOS Glaukos | Maintains: Buy | $115 → $160 | $120.87 | +32.37% | 10 | Jan 22, 2026 | |
| GMED Globus Medical | Reinstates: Hold | $64 | $94.38 | -32.19% | 1 | Oct 28, 2025 | |
| RXST RxSight | Maintains: Hold | $33 → $28 | $7.20 | +288.89% | 10 | Mar 19, 2025 | |
| BLCO Bausch + Lomb | Maintains: Hold | $19 → $18 | $15.78 | +14.07% | 3 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $2 | $1.05 | +90.48% | 2 | May 15, 2024 |
TransMedics Group
Mar 9, 2026
Maintains: Hold
Price Target: $115 → $130
Current: $113.21
Upside: +14.83%
Orthofix Medical
Mar 9, 2026
Maintains: Buy
Price Target: $22 → $18
Current: $12.15
Upside: +48.15%
Alphatec Holdings
Mar 9, 2026
Maintains: Buy
Price Target: $24 → $20
Current: $10.21
Upside: +95.89%
Alcon
Mar 9, 2026
Maintains: Hold
Price Target: $80 → $82
Current: $75.86
Upside: +8.09%
STAAR Surgical Company
Mar 4, 2026
Maintains: Hold
Price Target: $19 → $18
Current: $24.84
Upside: -27.54%
Sight Sciences
Mar 2, 2026
Maintains: Buy
Price Target: $6 → $8
Current: $4.32
Upside: +85.19%
Glaukos
Jan 22, 2026
Maintains: Buy
Price Target: $115 → $160
Current: $120.87
Upside: +32.37%
Globus Medical
Oct 28, 2025
Reinstates: Hold
Price Target: $64
Current: $94.38
Upside: -32.19%
RxSight
Mar 19, 2025
Maintains: Hold
Price Target: $33 → $28
Current: $7.20
Upside: +288.89%
Bausch + Lomb
Jan 29, 2025
Maintains: Hold
Price Target: $19 → $18
Current: $15.78
Upside: +14.07%
May 15, 2024
Maintains: Hold
Price Target: $2
Current: $1.05
Upside: +90.48%